QIAGEN Total Assets 2010-2022 | QGEN
QIAGEN total assets from 2010 to 2022. Total assets can be defined as the sum of all assets on a company's balance sheet.
- QIAGEN total assets for the quarter ending December 31, 2022 were $6.288B, a 2.29% increase year-over-year.
- QIAGEN total assets for 2022 were $6.288B, a 2.29% increase from 2021.
- QIAGEN total assets for 2021 were $6.147B, a 4.72% increase from 2020.
- QIAGEN total assets for 2020 were $5.87B, a 12.11% increase from 2019.
QIAGEN Annual Total Assets
(Millions of US $) |
| 2022 |
$6,288 |
| 2021 |
$6,147 |
| 2020 |
$5,870 |
| 2019 |
$5,236 |
| 2018 |
$5,748 |
| 2017 |
$5,039 |
| 2016 |
$4,308 |
| 2015 |
$4,179 |
| 2014 |
$4,454 |
| 2013 |
$4,088 |
| 2012 |
$4,088 |
| 2011 |
$3,730 |
| 2010 |
$3,914 |
| 2009 |
$3,796 |
QIAGEN Quarterly Total Assets
(Millions of US $) |
| 2022-12-31 |
$6,288 |
| 2022-09-30 |
$6,517 |
| 2022-06-30 |
$6,154 |
| 2022-03-31 |
$6,184 |
| 2021-12-31 |
$6,147 |
| 2021-09-30 |
$6,043 |
| 2021-06-30 |
$5,907 |
| 2021-03-31 |
$5,763 |
| 2020-12-31 |
$5,870 |
| 2020-09-30 |
$5,771 |
| 2020-06-30 |
$5,295 |
| 2020-03-31 |
$5,181 |
| 2019-12-31 |
$5,236 |
| 2019-09-30 |
$5,143 |
| 2019-06-30 |
$5,383 |
| 2019-03-31 |
$5,420 |
| 2018-12-31 |
$5,748 |
| 2018-09-30 |
$5,299 |
| 2018-06-30 |
$5,309 |
| 2018-03-31 |
$5,105 |
| 2017-12-31 |
$5,039 |
| 2017-09-30 |
$5,097 |
| 2017-06-30 |
$4,556 |
| 2017-03-31 |
$4,068 |
| 2016-12-31 |
$4,308 |
| 2016-09-30 |
$4,328 |
| 2016-06-30 |
$4,119 |
| 2016-03-31 |
$4,120 |
| 2015-12-31 |
$4,179 |
| 2015-09-30 |
$4,159 |
| 2015-06-30 |
$4,131 |
| 2015-03-31 |
$4,170 |
| 2014-12-31 |
$4,454 |
| 2014-09-30 |
$4,461 |
| 2014-06-30 |
$4,564 |
| 2014-03-31 |
$4,487 |
| 2013-12-31 |
$4,088 |
| 2013-09-30 |
$4,055 |
| 2013-06-30 |
$3,976 |
| 2013-03-31 |
$4,034 |
| 2012-12-31 |
$4,088 |
| 2012-09-30 |
$3,956 |
| 2012-06-30 |
$3,877 |
| 2012-03-31 |
$3,798 |
| 2011-12-31 |
$3,730 |
| 2011-09-30 |
$3,948 |
| 2011-06-30 |
$3,998 |
| 2011-03-31 |
$3,958 |
| 2010-12-31 |
$3,914 |
| 2010-09-30 |
$3,891 |
| 2010-06-30 |
$3,768 |
| 2010-03-31 |
$3,780 |
| 2009-12-31 |
$3,796 |
| 2009-09-30 |
$3,755 |
| 2009-06-30 |
$2,971 |
| 2009-03-31 |
$2,832 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Biomedical and Genetics |
$10.416B |
$2.142B |
|
QIAGEN N.V. is one of the world's leading providers of technologies and products for the separation, purification and handling of nucleic acids DNA/RNA. The company provides innovative technologies and products for pre-analytical sample preparation and molecular diagnostics solutions. It has developed a comprehensive portfolio of proprietary, consumable products, and automated solutions for sample collection. Qiagen has subsidiaries several other countries with good sales potential. Segment Details Consumables: These are typically sample preparation or test kits that contain all the necessary reagents and buffers, and a manual including protocols and relevant background information. Automated Instruments: These automate the use of Sample & Assay Technologies into efficient solutions for a broad range of laboratory needs. Customer Classes: QIAGEN focuses on 4 principal segments or customer classes for sample and assay technologies:? Molecular Diagnostics, Applied Testing, Pharma and Academia.
|
